Arginine vasopressin AVP and treatment with arginine vasopressin receptor antagonists vaptans in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion SIADHReport as inadecuate




Arginine vasopressin AVP and treatment with arginine vasopressin receptor antagonists vaptans in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion SIADH - Download this document for free, or read online. Document in PDF available to download.

* Corresponding author 1 Department of Internal Medicine III 2 Department of Medicine II 3 Department of Nephrology 4 Department of Pharmacology

Abstract : Arginine vasopressin AVP is the major physiological regulator of renal water excretion and blood volume. The AVP pathways of VR-mediated vasoconstriction and VR-induced water retention represent a potentially attractive target of therapy for edematous diseases. Experimental and clinical evidence suggests beneficial effects of AVP receptor antagonists by increasing free water excretion and serum sodium levels. This review provides an update on the therapeutic implication of newly developed AVP receptor antagonists in respective disorders, such as chronic heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion.

Keywords : Vasopressin Vaptans Hyponatremia Heart failure SIADH





Author: Natig Gassanov - Nasser Semmo - Mariam Semmo - Amir M. Nia - Uwe Fuhr - Fikret Er -

Source: https://hal.archives-ouvertes.fr/



DOWNLOAD PDF




Related documents